PAVmed (PAVM) Other Accumulated Expenses (2016 - 2024)
PAVmed's (PAVM) quarterly Other Accumulated Expenses came in at $652000.0 in Q4 2024, up 183.48% quarter-over-quarter from $230000.0 in Q2 2020.
PAVmed (PAVM) Other Accumulated Expenses (2016 - 2024) Analysis & Trends
PAVmed's Other Accumulated Expenses history runs 6 years deep, the most recent figure standing at $652000.0 for Q4 2024.
- On a quarterly basis, Other Accumulated Expenses changed N/A year-over-year to $652000.0 in Q4 2024; TTM through Dec 2024 was $652000.0, a N/A change from a year earlier, with the FY2024 full-year figure at $652000.0, changed N/A from the prior year.
- Other Accumulated Expenses grew to $652000.0 in Q4 2024 per PAVM's latest filing, from $230000.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $652000.0 in Q4 2024 and bottomed at $160000.0 in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.66 Bn | 175.36 Bn | 6.27 Bn |
| 2 | Stryker | 128.55 Bn | 125.68 Bn | 3.81 Bn |
| 3 | Medtronic | 108.38 Bn | 99.16 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.11 Bn | 66.66 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.19 Bn | 43.52 Bn | 1.29 Bn |
| 6 | Dexcom | 28.54 Bn | 27.42 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.37 Bn | 26.09 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.90 Bn | 26.33 Bn | - |
| 9 | Koninklijke Philips | 25.53 Bn | 22.40 Bn | 2.07 Bn |
| 10 | PAVmed | 10.89 Mn | 9.36 Mn | -4,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 652,000.00 |
| Jun 30, 2020 | 230,000.00 |
| Mar 31, 2020 | 160,000.00 |
| Dec 31, 2019 | 88,000.00 |
| Jun 30, 2019 | 191,933.00 |
| Mar 31, 2019 | 41,090.00 |
| Dec 31, 2018 | 49,872.00 |
| Sep 30, 2018 | 55,311.00 |
| Jun 30, 2018 | 94,247.00 |
| Mar 31, 2018 | 3,108.00 |
| Dec 31, 2017 | 11,203.00 |
| Sep 30, 2017 | 51,750.00 |
| Jun 30, 2017 | 69,000.00 |
| Dec 31, 2016 | 28,000.00 |